In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
In the latest session, VolitionRX Ltd (AMEX: VNRX) closed at $0.3 down -3.76% from its previous closing price of $0.31. In other words, the price has decreased by -$3.76 from its previous closing price. On the day, 1.81 million shares were traded. VNRX stock price reached its highest trading level at $0.3363 during the session, while it also had its lowest trading level at $0.28.
Ratios:
For a deeper understanding of VolitionRX Ltd’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.12 and its Current Ratio is at 0.12.
Upgrades & Downgrades
In the most recent recommendation for this company, H.C. Wainwright on April 08, 2025, initiated with a Buy rating and assigned the stock a target price of $2.50.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 17 ’25 when Reynolds Cameron John bought 20,000 shares for $0.35 per share. The transaction valued at 7,000 led to the insider holds 2,554,847 shares of the business.
Reynolds Cameron John bought 110,000 shares of VNRX for $56,100 on Oct 14 ’25. The President and CEO now owns 2,534,847 shares after completing the transaction at $0.51 per share. On Oct 14 ’25, another insider, Innes Guy Archibald, who serves as the Director of the company, bought 96,153 shares for $0.51 each. As a result, the insider paid 49,038 and bolstered with 1,062,967 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VNRX now has a Market Capitalization of 36803628 and an Enterprise Value of 46548372. For the stock, the TTM Price-to-Sale (P/S) ratio is 25.03. Its current Enterprise Value per Revenue stands at 31.622 whereas that against EBITDA is -2.15.
Stock Price History:
The Beta on a monthly basis for VNRX is 1.22, which has changed by -0.4915254 over the last 52 weeks, in comparison to a change of 0.13506866 over the same period for the S&P500. Over the past 52 weeks, VNRX has reached a high of $0.94, while it has fallen to a 52-week low of $0.27. The 50-Day Moving Average of the stock is -31.05%, while the 200-Day Moving Average is calculated to be -46.51%.
Shares Statistics:
For the past three months, VNRX has traded an average of 1.27M shares per day and 4494200 over the past ten days. A total of 109.62M shares are outstanding, with a floating share count of 96.62M. Insiders hold about 21.32% of the company’s shares, while institutions hold 21.27% stake in the company. Shares short for VNRX as of 1763078400 were 362805 with a Short Ratio of 0.29, compared to 1760486400 on 266027. Therefore, it implies a Short% of Shares Outstanding of 362805 and a Short% of Float of 0.38999999999999996.
Earnings Estimates
The market rating for VolitionRX Ltd (VNRX) is a result of the insights provided by 3.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$0.04, with high estimates of -$0.04 and low estimates of -$0.04.
Analysts are recommending an EPS of between -$0.2 and -$0.24 for the fiscal current year, implying an average EPS of -$0.21. EPS for the following year is -$0.09, with 4.0 analysts recommending between $0.08 and -$0.15.
Revenue Estimates
A total of 6 analysts believe the company’s revenue will be $714.08k this quarter.It ranges from a high estimate of $868k to a low estimate of $560k. As of. The current estimate, VolitionRX Ltd’s year-ago sales were $191.66kFor the next quarter, 6 analysts are estimating revenue of $806.25k. There is a high estimate of $1.2M for the next quarter, whereas the lowest estimate is $600k.
A total of 5 analysts have provided revenue estimates for VNRX’s current fiscal year. The highest revenue estimate was $2.15M, while the lowest revenue estimate was $1.8M, resulting in an average revenue estimate of $1.95M. In the same quarter a year ago, actual revenue was $1.23MBased on 5 analysts’ estimates, the company’s revenue will be $9.19M in the next fiscal year. The high estimate is $29.26M and the low estimate is $2.78M.
